Research Studies
Risk Factors
Established and Probable
Body weight and breast cancer risk | |
Weight gain and the risk of breast cancer | |
Alcohol consumption and breast cancer risk | |
Recreational physical activity and breast cancer risk | |
Breastfeeding and breast cancer risk | |
Blood estrogen levels and the risk of breast cancer | |
Postmenopausal hormone use and breast cancer risk | |
Birth control pills and breast cancer risk | |
Age at menopause and breast cancer risk women | |
BRCA 1 or 2 gene mutations and cancer risk | |
Hyperplasia and breast cancer risk | |
Light at night/shift work and breast cancer risk | |
Factors Under Study
Dietary fat consumption and breast cancer risk | |
Fruit and vegetable consumption and breast cancer risk | |
Carotenoid intake and breast cancer risk | |
Soy intake and breast cancer risk | |
Dairy/milk consumption and breast cancer risk | |
Meat consumption and breast cancer risk | |
IGF-1 and breast cancer risk | |
Smoking and breast cancer risk | |
Secondhand smoke and breast cancer risk | |
Factors Not Related to Breast Cancer
Electromagnetic fields and breast cancer risk | |
Blood organochlorine levels and breast cancer risk | |
Abortion and breast cancer risk | |
Hair dyes and breast cancer risk | |
Breast implants and breast cancer risk | |
Risk–lowering drugs (Chemoprevention)
Chemoprevention—the use of tamoxifen and raloxifene to reduce the risk of breast cancer | |
Early Detection and Screening
Breast cancer screening with mammography for ages 40–49 | |
Breast cancer screening with mammography for ages 50–69 | |
Breast cancer screening with mammography for ages 70 and older | |
Digital mammography versus standard mammography for breast cancer screening | |
MRI plus mammography versus mammography alone for high-risk women | |
Diagnosis and Prognostic Factors
Lymph node status and breast cancer survival | |
Accuracy of sentinel node biopsy in predicting axillary lymph node status | |
Tumor size and breast cancer survival | |
Estrogen receptor status and overall survival | |
Treatment
Mastectomy versus breast conserving surgery plus radiation and overall survival in early breast cancer | |
Radiation therapy following mastectomy and overall survival in stage II & III breast cancer | |
Adjuvant chemotherapy and overall survival | |
Different adjuvant chemotherapy regimens and overall survival in early breast cancer | |
Selected short-term side effects of adjuvant chemotherapy for breast cancer | |
Adjuvant tamoxifen and overall survival in estrogen receptor-positive breast cancer | |
Trastuzumab (Herceptin) and overall survival in early breast cancer | |
Aromatase inhibitors and disease free survival in early breast cancer | |
Use of tamoxifen in the treatment of ductal carcinoma in situ (DCIS) | |
Neoadjuvant (preoperative) chemotherapy for women with stage II or stage III breast cancer | |
Neoadjuvant (preoperative) hormonal therapy for women with estrogen receptor-positive breast cancer | |
High-dose chemotherapy with stem cell transplant for women with metastatic breast cancer and for women with non-metastatic breast cancer at high risk for recurrence | |
Combined modality treatment and overall survival in inflammatory breast cancer | |
Trastuzumab (Herceptin) and overall response rate in metastatic breast cancer | |
Support
Support groups and breast cancer survival | |
Social support and breast cancer survival | |
Getting Good Care
Hospital volume and breast cancer survival after treatment | |
Geographic variation in rates of mastectomy | |
After Treatment
Pregnancy and breast cancer survival | |
Postmenopausal hormones and recurrence after breast cancer diagnosis | |
Total fat intake and breast cancer survival | |
Body weight and breast cancer survival | |
Physical activity and breast cancer survival | |
Black cohosh and relief of menopausal symptoms | |
Soy and relief of menopausal symptoms | |
Other supplements and relief of menopausal symptoms |
|
|



